U.S. markets closed
  • S&P 500

    4,187.62
    +7.45 (+0.18%)
     
  • Dow 30

    33,981.57
    -61.92 (-0.18%)
     
  • Nasdaq

    14,138.78
    +121.97 (+0.87%)
     
  • Russell 2000

    2,298.01
    +26.15 (+1.15%)
     
  • Crude Oil

    61.97
    -0.17 (-0.27%)
     
  • Gold

    1,781.10
    +3.30 (+0.19%)
     
  • Silver

    26.28
    +0.20 (+0.79%)
     
  • EUR/USD

    1.2093
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.5700
    +0.0030 (+0.19%)
     
  • GBP/USD

    1.3895
    +0.0015 (+0.11%)
     
  • USD/JPY

    108.0800
    +0.2150 (+0.20%)
     
  • BTC-USD

    52,825.39
    +3,303.08 (+6.67%)
     
  • CMC Crypto 200

    1,213.06
    +5.25 (+0.43%)
     
  • FTSE 100

    6,963.12
    +24.56 (+0.35%)
     
  • Nikkei 225

    29,126.23
    +105.60 (+0.36%)
     

Travere Therapeutics to Report First Quarter 2021 Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
Travere Therapeutics, Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2021 financial results on Thursday, May 6, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information

Date:

Thursday, May 6, 2021

Time:

4:30 p.m. ET

Dial-in numbers:

+1 (800) 773-2954 (U.S.) or +1 (847) 413-3731 (International)

Confirmation code:

50155370

Live webcast:

Travere.com in the “Events & Presentations” section of the “Investors” page

A replay of the call will be available from 7:30 p.m. ET, May 6, 2021 to 7:30 p.m. ET, May 13, 2021. The replay number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406 (International), confirmation code 50155370.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com